CO5261504A1 - Nuevos derivados de acidos carboxilicos, que llevan cadenas laterales ceto, su preparacion y utilizacion como antagonis- tas de los receptores de endotelina - Google Patents

Nuevos derivados de acidos carboxilicos, que llevan cadenas laterales ceto, su preparacion y utilizacion como antagonis- tas de los receptores de endotelina

Info

Publication number
CO5261504A1
CO5261504A1 CO99050715A CO99050715A CO5261504A1 CO 5261504 A1 CO5261504 A1 CO 5261504A1 CO 99050715 A CO99050715 A CO 99050715A CO 99050715 A CO99050715 A CO 99050715A CO 5261504 A1 CO5261504 A1 CO 5261504A1
Authority
CO
Colombia
Prior art keywords
alkyl
phenyl
optionally substituted
alkynyl
alkenyl
Prior art date
Application number
CO99050715A
Other languages
English (en)
Spanish (es)
Inventor
Wilhelm Amberg
Rolf Jansen
Georg Kettschau
Stefan Herms
Raschack Manfred
Unger Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of CO5261504A1 publication Critical patent/CO5261504A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CO99050715A 1998-08-10 1999-08-10 Nuevos derivados de acidos carboxilicos, que llevan cadenas laterales ceto, su preparacion y utilizacion como antagonis- tas de los receptores de endotelina CO5261504A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19836044A DE19836044A1 (de) 1998-08-10 1998-08-10 Neue Carbonsäurederivate, die Ketoseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten

Publications (1)

Publication Number Publication Date
CO5261504A1 true CO5261504A1 (es) 2003-03-31

Family

ID=7876981

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99050715A CO5261504A1 (es) 1998-08-10 1999-08-10 Nuevos derivados de acidos carboxilicos, que llevan cadenas laterales ceto, su preparacion y utilizacion como antagonis- tas de los receptores de endotelina

Country Status (22)

Country Link
EP (1) EP1104410A1 (ko)
JP (1) JP2002522531A (ko)
KR (1) KR20010072378A (ko)
CN (1) CN1323298A (ko)
AR (1) AR020147A1 (ko)
AU (1) AU5374199A (ko)
BG (1) BG105236A (ko)
BR (1) BR9912889A (ko)
CA (1) CA2340167A1 (ko)
CO (1) CO5261504A1 (ko)
DE (1) DE19836044A1 (ko)
HK (1) HK1042086A1 (ko)
HR (1) HRP20010164A2 (ko)
HU (1) HUP0104007A3 (ko)
ID (1) ID27965A (ko)
IL (1) IL140915A0 (ko)
NO (1) NO20010622D0 (ko)
PL (1) PL345998A1 (ko)
SK (1) SK832001A3 (ko)
TR (1) TR200100427T2 (ko)
WO (1) WO2000009489A1 (ko)
ZA (1) ZA200101975B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19924892A1 (de) * 1999-06-01 2000-12-07 Basf Ag Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636046A1 (de) * 1996-09-05 1998-03-12 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten

Also Published As

Publication number Publication date
PL345998A1 (en) 2002-01-14
AU5374199A (en) 2000-03-06
AR020147A1 (es) 2002-04-10
CN1323298A (zh) 2001-11-21
TR200100427T2 (tr) 2001-07-23
JP2002522531A (ja) 2002-07-23
NO20010622L (no) 2001-02-06
NO20010622D0 (no) 2001-02-06
HK1042086A1 (zh) 2002-08-02
KR20010072378A (ko) 2001-07-31
BG105236A (en) 2001-12-29
ZA200101975B (en) 2002-03-11
HUP0104007A3 (en) 2002-12-28
ID27965A (id) 2001-05-03
HRP20010164A2 (en) 2002-04-30
SK832001A3 (en) 2001-11-06
DE19836044A1 (de) 2000-02-17
IL140915A0 (en) 2002-02-10
HUP0104007A2 (hu) 2002-05-29
BR9912889A (pt) 2001-05-08
CA2340167A1 (en) 2000-02-24
EP1104410A1 (de) 2001-06-06
WO2000009489A1 (de) 2000-02-24

Similar Documents

Publication Publication Date Title
BRPI0606455A (pt) compostos farmacêuticos
AR054799A1 (es) Derivados de oxindol
AR049443A1 (es) Derivados de pirrolpiridinas
ECSP055974A (es) Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas
CO5060482A1 (es) Derivados terapeuticos de biarilo
AR038723A1 (es) Cumarinas utiles como biomarcadores
ES2422204T3 (es) Novedosos derivados de imidazolidin-2-ona como moduladores selectivos de receptor de andrógenos (SARMS)
AR035548A1 (es) Compuestos organicos
CO5080782A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa
CO5611131A2 (es) Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa
BRPI0606480A (pt) compostos farmacêuticos
AR052458A1 (es) Amino-imidazolonas para la inhibicion de beta-secretasa
AR044519A1 (es) Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
CY1105091T1 (el) Αντικατεστημενες ενωσεις 2-αρυλοβενζαζολιου και η χρηση τους σαν παραγοντες κατα των ογκων
CO5070570A1 (es) DERIVADOS DE TIROSINA COMO ACTIVADORES DE hPPAR Y hPPARalfa Y UNA COMPOSICION FARMACEUTICA QUE LOS CONTIENE
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
AR006906A1 (es) Derivados de indazol sustituidos, composiciones farmaceuticas que los contienen, uso de los mismos e intermediarios de sintesis
PE20091387A1 (es) Proceso de preparacion de derivados de tetrazol-5-il-bifenilo
UY26048A1 (es) Derivados de piridopiranoacepinas, su preparacion y su aplicacion terapeutica
CO5601021A2 (es) Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb
AR038276A1 (es) Metodos para incrementar la formacion osea.
CO5080791A1 (es) Derivados de la piperidina que tienen efectos sobre sistemas con serotonina
AR055666A1 (es) Inhibidores inntr
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
AR035650A1 (es) Procedimiento para la preparacion de compuestos de pirazolo[4,3-d]pirimidin-7-ona

Legal Events

Date Code Title Description
FA Application withdrawn